Friday, May 9, 2025
23.4 C
Bengaluru

Anup Soans

Reach out to Anup Soans: anupsoans@medicinman.net.

Indian Pharma Market Performance – April 2025

The Indian Pharmaceutical Market (IPM) maintained moderate growth in April 2025, expanding 7.8% year-on-year in value. Monthly sales reached...

The Future in Your Palm+Chemistry – Palmistry

The future in your palm - a non-contact wearable that studies skin flux to estimate health  A small device, just...

Nimesulide – Nice or Not Nise?

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic use. It has a well-documented...

MedicinMan Pharma Monitor March 2025

Indian Pharma Top Brands, Therapy & Regional Insights 🏆 Market Movers – Top 5 Brands by Value RankBrandCompanyTherapy Area₹ Value...

How Trump’s Tariff War Could Affect India’s Top 25 Pharma Companies

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends affordable medicines to millions of Americans, saving the U.S. healthcare...

Rx 2024 – Top 25 Drugs by Sales, Growth & Market Trends

The pharmaceutical market in 2024 saw major shifts driven by obesity, diabetes, and oncology treatments. Leading products like Merck’s...
spot_imgspot_img

India’s Medical Devices Market: Strategic Implications and Key Investors

KKR's Investments in India's Medical Devices Market: Strategic Implications and Key Investors Introduction The Indian medical devices sector is witnessing unprecedented...

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable medicines worldwide.India's pharma companies excel in domestic markets and international...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into their valuation, revenue performance, and industry trends In 2025, the Indian...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant area in healthcare, with over 50% of ongoing clinical trials...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the VUCA framework—Volatility, Uncertainty, Complexity, and Ambiguity—to understand and respond to...